Browse studies

Find your next paid study

6 recruiting studies matching your filters

Phase 1b Open-label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)

This Phase 1b basket trial will investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary efficacy of RAY121, a …

Antiphospholipid Syndrome (APS)Bullous Pemphigoid (BP)Behçet's Syndrome (BS)+3 more

Estimated

~$10 – $8,750

Chugai PharmaceuticalNCT06371417

Genetics of Antiphospholipid Antibody Syndrome

Antiphospholipid antibody syndrome (APS) is characterized by the presence of antiphospholipid antibodies, which are proteins in the blood that interfere with t…

Antiphospholipid Syndrome

Estimated

~$10 – $750

Duke UniversityNCT00482794

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

The PROMISSE Study is an observational study of 700 pregnant patients, enrolled at nine major clinical centers. The purpose of the study is 1) to determine whe…

Systemic Lupus ErythematosusAntiphospholipid Syndrome

Estimated

~$10 – $750

Hospital for Special Surgery, New YorkNCT00198068

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Antiphospholipid Syndrome

Estimated

~$10 – $750

University of California, DavisNCT00616317

Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more

Estimated

~$10 – $750

Yale UniversityNCT04402086

Phase 2

Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)

This treatment trial evaluates the addition of an anti-tumor necrosis factor-alpha drug, certolizumab, to usual treatment (a heparin agent and low-dose aspirin…

High Risk PregnancyPregnancy ComplicationsAntiphospholipid Syndrome in Pregnancy+1 more

Estimated

~$10 – $7,500

David Ware BranchNCT03152058